An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial
2018 ◽
Vol 200
◽
pp. 17-23
◽
Renato D. Lopes
◽
Amit N. Vora
◽
Danny Liaw
◽
Christopher B. Granger
◽
Harald Darius
◽
...
Wonjae Lee
◽
Jung-Won Suh
◽
Jin Joo Park
◽
Chang-Hwan Yoon
◽
Young-Seok Cho
◽
...
2017 ◽
Vol 37
◽
pp. 43-48
Wail Nammas
◽
Adam de Belder
◽
Matti Niemelä
◽
Jussi Sia
◽
Hannu Romppanen
◽
...
2015 ◽
Vol 169
(4)
◽
pp. 472-478.e5
◽
C. Michael Gibson
◽
Roxana Mehran
◽
Christoph Bode
◽
Johnathan Halperin
◽
Freek Verheugt
◽
...
2020 ◽
Vol 76
(3)
◽
pp. 317-321
◽
Hiromasa Otake
◽
Takashi Kubo
◽
Toshiro Shinke
◽
Kiyoshi Hibi
◽
Shigemitsu Tanaka
◽
...
2017 ◽
Vol 38
(suppl_1)
◽
N.D. Fagel
◽
M. Maarse
◽
T. Slagboom
◽
J.P. Herrman
◽
R.J. Van Der Schaaf
◽
...
2018 ◽
Vol 72
(2)
◽
pp. 170-175
◽
Takashi Kubo
◽
Toshiro Shinke
◽
Takayuki Okamura
◽
Kiyoshi Hibi
◽
Gaku Nakazawa
◽
...
2008 ◽
Vol 2008
◽
pp. 207-209
Jingen Li
◽
Jianqing Ju
◽
Zhuo Chen
◽
Jing Liu
◽
Fang Lu
◽
...
2007 ◽
Vol 69
(6)
◽
pp. 801-807
◽
Nhan Nguyen
◽
Syed Hasan
◽
Lori Caufield
◽
Frederick S. Ling
◽
Craig R. Narins
Marieke L. Fokkema
◽
Pieter J. Vlaar
◽
Felix Zijlstra
Close
Export Citation Format
Close
Share Document
Close